Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in Europe and North America and approximately 1% in Asia and South America.

An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way.

The National Institutes of Health reports that more than 6.5 million people suffer from heart failure nationwide. And half of ...

Once largely a diagnosis of exclusion, new tools and treatments are unraveling some of the mysteries surrounding heart failure with preserved ejection fraction.

After securing Medicare reimbursement for its pacemaker-like heart failure (HF) implant, Impulse Dynamics has raised more ...

The outside advisors analyzed the results of the RELIEVE-HF pivotal trial, which randomized 508 patients to either receive ...

Ventura's permanent interatrial shunt was designed to shunt blood from the left to right atrium to improve symptoms in ...

Two NEJM trials report conflicting results on long-term beta-blockers after MI in patients with preserved ejection fraction, ...

SHREVEPORT, La. - Ochsner LSU Health Shreveport is one of only 40 hospitals nationwide selected for a new American Heart ...

Guideline-recommended therapies for heart failure (HF) were found to be ineffective in patients with HF caused by Chagas ...

An FDA advisory panel unanimously agreed that Johnson & Johnson MedTech's V-Wave Ventura interatrial shunt's risks outweigh ...